2025-08-07から1日間の記事一覧
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. Kelly RJ, Ajani JA, Kuzdzal J, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. Erratum in: N Engl J Med. 2023 Feb 16;388(7):672. …
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.Uboha NV, Basree MM, Eickhoff JC, et al. J Surg Oncol. 2025 Jun;131(7…
